Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
基本信息
- 批准号:10321554
- 负责人:
- 金额:$ 44.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAllelesAlzheimer&aposs DiseaseAmino Acid SequenceAutomobile DrivingAutophagocytosisBasic ScienceBiochemicalBiological SciencesBirthBrainBuffersCellsCessation of lifeCharacteristicsChemicalsCholesterolCholesterol HomeostasisClinicalDiseaseDisease ManagementDisease ProgressionEnvironmentEtiologyGRP geneGaussian modelGenesGeneticGenetic DiseasesGenetic VariationGenomeGenotypeGoalsHeat-Shock Proteins 70Heat-Shock ResponseHumanIndividualInheritedKnowledgeLate Onset Alzheimer DiseaseLeadLearningLightLipidsLysosomesMachine LearningModernizationMolecularMolecular ChaperonesMolecular Mechanisms of ActionNeurodegenerative DisordersNiemann-Pick DiseasesPathologyPathway interactionsPatientsPhenotypePopulationProcessProteinsRare DiseasesResolutionRoleSignal PathwaySpecificityStressStructureSystemTarget PopulationsTherapeuticTherapeutic InterventionTimeUbiquitinUncertaintyUnited States National Library of MedicineVariantbasebiochemical toolsbiophysical toolscell typecholesterol controldruggable targetearly onsetfitnessgenomic variationhuman modelimprovedinsightloss of functionmulticatalytic endopeptidase complexnervous system disordernovelpolypeptideprecision medicinepreventprognosticprotein foldingprotein functionprotein misfoldingproteostasisrare genetic disorderrare variantresponsesmall moleculetooltrafficking
项目摘要
Project Summary/Abstract
Understanding and treating genome abnormalities that lead to rare genetic neurodegenerative diseases such as
Niemann-Pick C1 globally managing cholesterol homeostasis, or APOE alleles impacting cholesterol
homeostasis in the brain triggering late-onset Alzheimer’s disease (LOAD), present a major challenge from both
basic science and clinical perspectives. We have developed a Gaussian process regression (GPR) based
machine learning (ML) approach that captures for the first time genomic variation in the population to understand
the spatial covariance (SCV) relationships contributing to sequence-to-function-to-structure relationships in the
individual. Genetic disease is fundamentally a problem of understanding the impact of altered folding
intermediates found in response to variation in the protein fold and how they are managed by proteostasis.
Proteostasis encompasses a broad range of chaperone and degradative components that manage the synthesis,
folding/stability and function of the protein fold in response to inherited and environmental stress and aging. The
general premise of this proposal is to develop a deep genome-based understanding of proteostasis that will
teach us how to manage genetic diseases triggered by folding stress. The rationale for this proposal is that
sparse genetic diversity found in the population, when used as a collective through application of GRP-ML
defined SCV relationships, can provide us on a residue-by-residue basis insight into the folding intermediates
that contribute to disease for the entire polypeptide sequence. The objective of this proposal is to understand
the role of proteostasis in managing this genetic diversity for the benefit of therapeutic intervention. We
hypothesize that management of the polypeptide fold of disease-causing variant proteins found in the population
by targeting the function of the multivalent Hsp40 and Hsp70 co-chaperone/chaperone branch (the Hsp70 axis)
of the proteostasis network will enable precision correction of misfolding phenotypes found in neurodegenerative
disease. Our approach will study the impact of variation in the Niemann Pick C1 (NPC1) gene. NPC1 is an
inherited, autosomal recessive, disorder characterized by the abnormal accumulation of unesterified cholesterol
and other lipids in late endosomal (LE) and lysosome (Ly) compartments of all cell types. The primary effect of
NPC1 variation results in early onset neurodegenerative disease in response to loss of cholesterol homeostasis.
In Aim 1 we will explore the ability of small molecules to allosterically regulate the activity of components of the
Hsp70 axis to retune the synthesis, folding/stability, trafficking and/or function of NPC1 variants. In Aim 2 we
will explore the molecular mechanism of action (MoA) of the Hsp70 axis components that are responsible for
enabling NPC1 variant correction. Completion of both aims will generate a comprehensive assessment of the
role of Hsp70 axis in NPC1 disease progression and will be used as a guide for advancement of a precision
medicine approach to reduce or prevent the onset of neurodegenerative disease triggered by genomic variation
in NPC1 population.
项目概要/摘要
了解和治疗导致罕见遗传性神经退行性疾病的基因组异常,例如
Niemann-Pick C1 在全球范围内管理胆固醇稳态,或影响胆固醇的 APOE 等位基因
大脑稳态引发迟发性阿尔茨海默氏病 (LOAD),这对两者提出了重大挑战
基础科学和临床观点。我们开发了基于高斯过程回归(GPR)的
机器学习 (ML) 方法首次捕获群体中的基因组变异以了解
空间协方差(SCV)关系有助于序列到功能到结构的关系
个人。遗传疾病从根本上来说是一个理解折叠改变影响的问题
响应蛋白质折叠变化的中间体以及它们如何通过蛋白质稳态进行管理。
蛋白质稳态涵盖了广泛的伴侣和降解成分,它们管理合成,
蛋白质折叠响应遗传和环境压力和衰老的折叠/稳定性和功能。这
该提案的总体前提是对蛋白质稳态进行基于基因组的深入理解,这将
教我们如何管理由折叠压力引发的遗传疾病。该提案的理由是
当通过应用 GRP-ML 作为一个集体使用时,在种群中发现稀疏的遗传多样性
定义的 SCV 关系,可以让我们在逐个残基的基础上深入了解折叠中间体
导致整个多肽序列的疾病。该提案的目的是了解
蛋白质稳态在管理这种遗传多样性以促进治疗干预方面的作用。我们
假设对人群中发现的致病变异蛋白的多肽折叠进行管理
通过靶向多价 Hsp40 和 Hsp70 共伴侣/伴侣分支(Hsp70 轴)的功能
蛋白质稳态网络的研究将能够精确纠正神经退行性疾病中发现的错误折叠表型
疾病。我们的方法将研究 Niemann Pick C1 (NPC1) 基因变异的影响。 NPC1 是一个
遗传性常染色体隐性遗传性疾病,其特征是未酯化胆固醇异常积累
以及所有细胞类型的晚期内体 (LE) 和溶酶体 (Ly) 区室中的其他脂质。主要作用为
NPC1 变异会导致早发性神经退行性疾病,以应对胆固醇稳态的丧失。
在目标 1 中,我们将探索小分子变构调节细胞组分活性的能力。
Hsp70 轴重新调整 NPC1 变体的合成、折叠/稳定性、运输和/或功能。在目标 2 中,我们
将探索 Hsp70 轴成分的分子作用机制 (MoA),这些成分负责
启用 NPC1 变异校正。这两个目标的完成将产生对
Hsp70 轴在 NPC1 疾病进展中的作用,将用作提高精确度的指南
减少或预防由基因组变异引发的神经退行性疾病发作的医学方法
在 NPC1 人群中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Edward Balch其他文献
William Edward Balch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Edward Balch', 18)}}的其他基金
Applying Spatial Covariance to Understand Human Variation in Genetic Disease
应用空间协方差来了解遗传疾病的人类变异
- 批准号:
10734426 - 财政年份:2023
- 资助金额:
$ 44.38万 - 项目类别:
Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
- 批准号:
10538562 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
Using Genetic Diversity to Manage Neurological Disease
利用遗传多样性来治疗神经系统疾病
- 批准号:
10706236 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
Modulation of Lung Disease by Genetic/Epigenetic Profiling
通过遗传/表观遗传分析调节肺部疾病
- 批准号:
10369651 - 财政年份:2010
- 资助金额:
$ 44.38万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




